Check your inbox
We just sent a link to your inbox. Click the link to continue signing in. Can’t find it? Check your spam & junk mail.
Didn't get a link?
Check your inbox
We just sent a link to your inbox. Click the link to continue registering. Can’t find it? Check your spam & junk mail.
Didn't get a link?
How often would you like to pay?
Your payment was interrupted
Exiting the registration flow at this point will mean you will loose your progress
For nearly a year, President Rodrigo Duterte used speech after speech to claim that salvation from the pandemic would come from one thing only: vaccines. Now, the Philippines is just weeks away from starting an immunization campaign that aims to deliver exactly that.
Vaccine czar Carlito Galvez Jr outlined the ambitious targets the government had for its vaccine program: secure at least 148 million vaccine doses and inoculate 50 million to 70 million Filipinos within 2021 – just enough to reach the recommended 60% of the population scientists estimated was needed to reach herd immunity against COVID-19.
In reaching these goals, Galvez, along with other pandemic and health officials face challenges that have stumped even the wealthiest of countries when distributing vaccines to the public.
With the distribution of the country’s first vaccine doses slated for February, the Duterte government’s timeline for its vaccine plan in 2021 hinges on many things – including delivery, storage, local government plans, and drawing up of masterlists – going right.
The Philippine government is in talks to secure vaccines from 7 companies, including Pfizer, AstraZeneca, Moderna, Novavax, Sinovac, Gamaleya, and Johnson & Johnson (Janssen Pharmaceutica).
Galvez said of the 7 companies, there were 5 with whom term sheets have been signed.
Term sheets are the second to the last document that needs to be signed. It sees companies commit to supplying doses for Filipinos.
Actual delivery and use will depend on details agreed upon in supply deals and whether the vaccine is granted emergency use authorization from the Philippine Food and Drug Administration.
As the main person in charge of vaccine negotiations for the Philippines, Galvez said supply deals were scheduled to be signed by the end of February. All contracts for vaccines were expected to be finalized by mid-February, he added.
In terms of preparations for the actual deployment of vaccines on the ground, various local government units (LGUs) have been running simulation exercises to rehearse their plans for storing, transporting, and distributing vaccines in their communities.
The Department of Health, along with task force officials, approved the vaccines plans of several LGUs in Metro Manila, with more expected to be cleared in the coming weeks.
Screenshot from National Task Force COVID-19
The first 117,000 doses of Pfizer and BioNTech’s vaccine will arrive in the Philippines in mid-February, courtesy of the COVAX facility led by the World Health Organization (WHO).
COVID-19 referral hospitals in Metro Manila – the epicenter of the pandemic in the country – will be prioritized for this supply. Galvez listed the following hospitals in particular:
Other vaccines like AstraZeneca which were expected to arrive in the first quarter will likewise be prioritized for frontline health workers caring for patients in high-risk areas or places where infections rates were still high. (The Philippines expected to receive at least 5 million doses of AstraZeneca’s vaccine from COVAX.)
Galvez said this phase of the government’s vaccine plan will be considered a “mini rollout” as it will cover some 1.7 million healthcare workers, along with other government frontliners who will be responsible for mounting the vaccine rollout in the coming months.
By this time, the government expects 10 to 15 million doses of vaccines to arrive in the country, on top of more vaccines to be supplied by COVAX.
WHO Philippines Representative Rabindra Abeyasignhe said the country is potentially looking at receiving a maximum of 9.2 million doses by March or April, while the remainder of the 44 million doses it was entitled to through COVAX will come at the end of the year.
The 9.2 million doses will be AstraZeneca’s vaccine manufactured in South Korea, though the actual amount will depend on manufacturing capacity, Abeyasinghe said.
Galvez said these vaccines will be used to inoculate members of vulnerable sector such as senior citizens and indigent Filipinos. The government is also eyeing to start the vaccination of “economic frontliners.”
During these months, supplies of AstraZeneca’s vaccine ordered by the private sector and local government units are also expected to start arriving in the country.
At this point, we should expect the Duterte government’s vaccine rollout to be in full swing as bulk of vaccines purchased should start arriving in the Philippines.
The number of doses to be made available in these months was somewhere between 30 million to 50 million, Galvez said. The amount would be enough to start inoculating about 25 million Filipinos.
Based on negotiations, some of the vaccines that may be delivered during these months include those developed by US pharmaceutical firms Moderna and Novavax.
In the latter months of the year, what Galvez described as the “full rollout” of vaccines will continue as bulk of vaccines procured through negotiations will be delivered.
These months will be crucial if the Duterte government is to reach its goal of inoculating 50 million to 70 million Filipinos. Galvez spelled out the stakes in the campaign, saying the country needed to reach this number if it is to achieve herd immunity and jumpstart economic recovery. – Rappler.com
Read Rappler's series of explainers on the Duterte government's vaccine program below: